Novavax begins early-stage trial for combined flu/Covid vaccine

Novavax begins testing a combination flu-Covid vaccine, with initial results expected in 2022. The goal is vaccinate a person against flu and Covid at the same time.

Powered by NewsAPI , in News on .

news image
Novavax begins testing a combination flu-Covid vaccine, with initial results expected in 2022. The goal is vaccinate a person against flu and Covid at the same time.
Read More